The Quantellect read.As of Nov 19, 2026, 17 active firms cover Thermo Fisher Scientific Inc: 13 rate it Buy or better, 4 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets span $520.00 to $760.00, a moderate spread. The average target of $649.24 sits 6% below the current $692.36. The rating mix has stayed broadly stable, with Buy-side ratings easing from 14 to 13 over recent months. On the fundamentals, the Street sees consensus EPS building from about $6.05 next quarter toward $27.78 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS17 active firms
Buy
Strong Buy00%
Buy1376%
Neutral424%
Sell00%
Strong Sell00%
Based on 17 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$649.24
-6.2% downside
Average target across 17 active firms as of Nov 19, 2026 vs $692.36 current
Highest Target$760.00
Average Target$649.24
Lowest Target$520.00
Detailed analyst forecasts for TMO
Showing 1–17 of 17 named analysts shown · 17 active firms in the rating projection
As of Nov 19, 2026, 13 of 17 active firms rate TMO a Buy (4 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
TMO EPS & revenue forecast
EPS · NEXT QUARTER
$6.05
Range $5.64 – $6.53 · 13 analysts · +11% YoY
Next period, 13 analysts expect Thermo Fisher Scientific Inc to earn $6.05 a share (range $5.64 – $6.53), versus $5.44 a year earlier. Full-year consensus is $25.28, growing to $27.78 the year after.
REVENUE · NEXT QUARTER
$11.7B
Range $11.6B – $12.0B · 13 analysts · +7% YoY
Revenue is expected to reach $11.7B (range $11.6B – $12.0B), +6.7% year-over-year. Full-year consensus is $48.0B, rising to $50.5B next year.
Top analysts covering Thermo Fisher Scientific Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on TMO.
#1
Puneet Souda
Leerink Partners · Rank #30
Buy
$580.00-16.2% to target
Overall win rate
57%
+ Follow
#2
SJ
Sung Ji Nam
Scotiabank · Rank #186
Buy
$590.00-14.8% to target
Overall win rate
47%
+ Follow
#3
Luke Sergott
Barclays · Rank #267
Buy
$750.00+8.3% to target
Overall win rate
43%
+ Follow
#4
David Westenberg
Piper Sandler · Rank #314
Neutral
$600.00-13.3% to target
Overall win rate
35%
+ Follow
#5
Vijay Kumar
Evercore ISI Group · Rank #331
Buy
$570.00-17.7% to target
Overall win rate
36%
+ Follow
TMO stock forecast FAQ
What is TMO's average 12-month price target?+
The 17 active firms with a live target average $649.24 for Thermo Fisher Scientific Inc over the next 12 months, ranging from a $760.00 high to a $520.00 low, as of Nov 19, 2026.
Is TMO stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 17 active firms as of Nov 19, 2026, 13 rate it Buy or Strong Buy, 4 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for TMO?+
The Street-high target is $760.00 (TD Cowen), and the Street-low is $520.00 (Bernstein). The average of all 17 active-firm targets is $649.24.
How many active Wall Street firms cover TMO?+
17 active firms have a recognized rating on Thermo Fisher Scientific Inc as of Nov 19, 2026, and 17 active firms carry a live 12-month price target.
Who is the most accurate analyst covering TMO?+
Among analysts who currently cover TMO, Puneet Souda of Leerink Partners has the strongest overall Quantellect track record (Rank #30). Their current call is Buy with a $580.00 target.
What is Thermo Fisher Scientific Inc's projected EPS for next quarter?+
The consensus estimate is $6.05 per share (range $5.64 – $6.53) across 13 analysts. Full-year EPS is projected at $25.28, rising to $27.78 the following year.
How much revenue is Thermo Fisher Scientific Inc expected to report next quarter?+
Consensus revenue is $11.7B (range $11.6B – $12.0B). Full-year revenue is projected at $48.0B, growing to $50.5B next year.
Have analysts been upgrading or downgrading TMO lately?+
As of Nov 19, 2026, 13 of 17 active firms rate TMO a Buy (4 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their TMO calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.